immune checkpoint inhibitor (Pierre Fabre)

N/A

Report date: 2025/03/20 15:35:57

Base Information

Drug Nameimmune checkpoint inhibitor (Pierre Fabre)
Drug Alias Nameimmune checkpoint targeting mAbs (Igenica)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunostimulantsT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIgenica
China Registration ClassN/A

Develop Information

Active CompaniesPierre Fabre Ltd
Inactive CompaniesIgenica
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A